Literature DB >> 25301883

Structural and genetic assessment of the ABCA4-associated optical gap phenotype.

Kalev Nõupuu1, Winston Lee2, Jana Zernant2, Stephen H Tsang3, Rando Allikmets3.   

Abstract

PURPOSE: To investigate the developmental stages and genetic etiology of the optical gap phenotype in recessive Stargardt disease (STGD1).
METHODS: Single and longitudinal data points from 15 patients, including four sibling pairs, exhibiting an optical gap phenotype on spectral-domain optical coherence tomography (SD-OCT) with confirmed disease-causing ABCA4 alleles were retrospectively analyzed. Fundus images with corresponding SD-OCT scans were collected with a confocal scanning laser ophthalmoscope. Structural phenotypes were assigned to three developmental stages according to SD-OCT. The ABCA4 gene was screened in all patients.
RESULTS: At least two disease-causing ABCA4 variants where identified in each patient; all except one (91%) were compound heterozygous for the p.G1961E mutation. All patients exhibited structural findings on SD-OCT that grouped into three progressive developmental stages over several years. Stage 1 was characterized by mild disruptions of the ellipsoid zone (EZ) band over the fovea. Stage 2 was a progressive expansion of the EZ band loss resulting in an empty lesion devoid of photoreceptors. Stage 3 observed a structural collapse of the inner retinal layers into the optical gap space leading to involvement and atrophy of the RPE thereafter.
CONCLUSIONS: The optical gap phenotype in STGD1 can be structurally divided into three progressive stages spanning several years. This particular phenotype also appears to be highly associated with the p.G1961E mutation of ABCA4. Taken together, it appears that a focal loss of photoreceptors sequentially precedes RPE dysfunction in the early development of ABCA4-associated optical gap lesions. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  ABCA4; Stargardt disease; optical coherence tomography; optical gap; p.G1961E mutation

Mesh:

Substances:

Year:  2014        PMID: 25301883      PMCID: PMC4228863          DOI: 10.1167/iovs.14-14674

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

2.  High-resolution optical coherence tomography imaging in KCNV2 retinopathy.

Authors:  Panagiotis I Sergouniotis; Graham E Holder; Anthony G Robson; Michel Michaelides; Andrew R Webster; Anthony T Moore
Journal:  Br J Ophthalmol       Date:  2011-05-10       Impact factor: 4.638

3.  Analysis of the ABCA4 gene by next-generation sequencing.

Authors:  Jana Zernant; Carl Schubert; Kate M Im; Tomas Burke; Carolyn M Brown; Gerald A Fishman; Stephen H Tsang; Peter Gouras; Michael Dean; Rando Allikmets
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

4.  Multifocal electroretinography in patients with Stargardt's macular dystrophy.

Authors:  U Kretschmann; M W Seeliger; K Ruether; T Usui; E Apfelstedt-Sylla; E Zrenner
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

5.  Foveal cavitation as an optical coherence tomography finding in central cone dysfunction.

Authors:  Theodore Leng; Michael F Marmor; Ulrich Kellner; Dorothy A Thompson; Agnes B Renner; William Moore; Jane C Sowden
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

6.  The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells.

Authors:  J R Sparrow; K Nakanishi; C A Parish
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

7.  Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography.

Authors:  Sang Jun Park; Se Joon Woo; Kyu Hyung Park; Jeong-Min Hwang; Hum Chung
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

8.  Pseudocystic foveal cavitation in tamoxifen retinopathy.

Authors:  Rishi R Doshi; Jorge A Fortun; Brian T Kim; Sander R Dubovy; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2014-02-26       Impact factor: 5.258

9.  ATP-binding cassette transporter ABCA4 and chemical isomerization protect photoreceptor cells from the toxic accumulation of excess 11-cis-retinal.

Authors:  Faraz Quazi; Robert S Molday
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-20       Impact factor: 11.205

10.  Diagnostic fundus autofluorescence patterns in achromatopsia.

Authors:  Abigail T Fahim; Naheed W Khan; Sarwar Zahid; Ira H Schachar; Kari Branham; Susanne Kohl; Bernd Wissinger; Victor M Elner; John R Heckenlively; Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2013-08-20       Impact factor: 5.258

View more
  16 in total

1.  Recessive Stargardt disease phenocopying hydroxychloroquine retinopathy.

Authors:  Kalev Nõupuu; Winston Lee; Jana Zernant; Vivienne C Greenstein; Stephen Tsang; Rando Allikmets
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-28       Impact factor: 3.117

2.  Laser-Induced Photic Injury Phenocopies Macular Dystrophy.

Authors:  Lijuan Zhang; Andrew Zheng; Hongping Nie; Kavita V Bhavsar; Yu Xu; David H Sliney; Stephen L Trokel; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2016       Impact factor: 1.803

Review 3.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

4.  The Rapid-Onset Chorioretinopathy Phenotype of ABCA4 Disease.

Authors:  Koji Tanaka; Winston Lee; Jana Zernant; Kaspar Schuerch; Lyam Ciccone; Stephen H Tsang; Janet R Sparrow; Rando Allikmets
Journal:  Ophthalmology       Date:  2017-09-22       Impact factor: 12.079

5.  Deep Scleral Exposure: A Degenerative Outcome of End-Stage Stargardt Disease.

Authors:  Winston Lee; Jana Zernant; Takayuki Nagasaki; Stephen H Tsang; Rando Allikmets
Journal:  Am J Ophthalmol       Date:  2018-07-26       Impact factor: 5.258

6.  Stargardt disease: monitoring incidence and diagnostic trends in the Netherlands using a nationwide disease registry.

Authors:  Esmee H Runhart; Patty Dhooge; Magda Meester-Smoor; Jeroen Pas; Jan Willem R Pott; Redmer van Leeuwen; Hester Y Kroes; Arthur A Bergen; Yvonne de Jong-Hesse; Alberta A Thiadens; Mary J van Schooneveld; Maria van Genderen; Camiel Boon; Caroline Klaver; L Ingeborg van den Born; Frans P M Cremers; Carel B Hoyng
Journal:  Acta Ophthalmol       Date:  2021-08-25       Impact factor: 3.988

7.  Phenotypic Differences in a PRPH2 Mutation in Members of the Same Family Assessed with OCT and OCTA.

Authors:  Henar Albertos-Arranz; Xavier Sánchez-Sáez; Natalia Martínez-Gil; Isabel Pinilla; Rosa M Coco-Martin; Jesús Delgado; Nicolás Cuenca
Journal:  Diagnostics (Basel)       Date:  2021-04-26

8.  Targeted next-generation sequencing identifies ABCA4 mutations in Chinese families with childhood-onset and adult-onset Stargardt disease.

Authors:  Ling-Hui Qu; Xin Jin; Chao Zeng; Nian-Gou Zhou; Yan-Hong Liu; Ye Lin
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

9.  Cis-acting modifiers in the ABCA4 locus contribute to the penetrance of the major disease-causing variant in Stargardt disease.

Authors:  Winston Lee; Jana Zernant; Takayuki Nagasaki; Laurie L Molday; Pei-Yin Su; Gerald A Fishman; Stephen H Tsang; Robert S Molday; Rando Allikmets
Journal:  Hum Mol Genet       Date:  2021-06-26       Impact factor: 5.121

10.  Complex inheritance of ABCA4 disease: four mutations in a family with multiple macular phenotypes.

Authors:  Winston Lee; Yajing Xie; Jana Zernant; Bo Yuan; Srilaxmi Bearelly; Stephen H Tsang; James R Lupski; Rando Allikmets
Journal:  Hum Genet       Date:  2015-11-02       Impact factor: 5.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.